Cresset and InoCardia to develop in silico cardiac safety assay for drug candidate screening
Cambridge, UK – 9th June 2020 – Cresset Discovery Services, provider of contract research services for early phase discovery, and ...
Welwyn Garden City, UK – 20th November 2012 – Cresset, innovative provider of chemistry software and services, announces that Es-is Technologies Ltd has chosen to license Torch for use in enzyme engineering. Torch is Cresset’s desktop molecular design software, widely used by medicinal chemists for drug design.
“The decision of Es-is, an enzyme design company, to work with Torch demonstrates the flexibility of our products and the value and insight that they bring to researchers working outside our core base of small molecule drug design,” says Dr David Bardsley, Cresset’s Sales Director.
Dr Amit Kessel, Head of Computational R&D at Es-is says, “We are excited about using torchV10 for the rational engineering of enzymes. We design novel enzyme-based syntheses for active ingredients in pharmaceutical drugs and our computational design process relies on a rational approach. Torch will provide us with valuable information about enzyme-substrate electrostatic interactions, helping us to streamline our processes.”
Dr Bardsley adds, “Cresset’s software works at the meeting point of chemistry and biology, giving chemists a way of understanding their molecules in terms of biological activity. Cresset’s technology and services are providing companies with the right information, wherever they sit in the drug design workflow.”